Form 4: Arvinas Officer Sells Shares for Tax Withholding

Arvinas Chief Scientific Officer Angela M. Cacace sold 2,576 shares of common stock to cover tax withholding obligations related to restricted stock units.

Summary

• Angela M. Cacace, Chief Scientific Officer at Arvinas, Inc., reported a transaction on June 17, 2026.
• The transaction involved the sale of 2,576 shares of common stock at a price of $7.595 per share.
• This sale was executed automatically by the issuer to cover tax withholding obligations.
• The shares were related to the vesting and settlement of restricted stock units (RSUs) granted on June 17, 2024.
• The sale was made pursuant to a pre-arranged, durable sale instruction intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
• Following this transaction, Cacace beneficially owns 180,390 shares of Arvinas common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While a sale of shares can sometimes be perceived negatively, the clear explanation of tax withholding and the use of a Rule 10b5-1(c) plan indicate a routine, non-discretionary transaction.

Positives

• The sale was part of a pre-planned, automatic process to cover tax liabilities, indicating a structured approach to compensation and tax management.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, which can provide an affirmative defense against insider trading allegations.
• The reporting person continues to hold a significant number of shares (180,390) after the transaction.

Negatives

• A portion of the reporting person's equity compensation was sold, which could be perceived negatively by the market if interpreted as a lack of confidence, although the filing clarifies it's for tax purposes.
• The sale price of $7.595 per share is noted, but without prior share price context, its significance is unclear.

Risks

• The filing does not explicitly mention any new risks or challenges.
• The primary risk associated with such transactions is the potential for misinterpretation by the market regarding the insider's intent, despite the Rule 10b5-1(c) plan.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future company performance. It solely reports a past transaction.

Management Comments

• "This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on June 17, 2024 pursuant to a durable sale instruction."
• "The sale does not represent a discretionary trade."

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and often involve sales for tax withholding purposes, especially with equity compensation. The use of a Rule 10b5-1(c) plan is a standard practice to mitigate insider trading concerns.

Stakeholder Impact

• Shareholders: The sale is for tax purposes and executed under a pre-arranged plan, so direct impact on share price due to perceived insider selling is likely minimal. However, any sale can contribute to overall selling pressure.
• Employees: This transaction highlights the use of equity compensation and the associated tax implications for executives.
• Management: Demonstrates adherence to compliance procedures for equity transactions.

Next Steps

• Continued monitoring of insider transactions for Arvinas, Inc.

Key Dates

Keywords

Arvinas, ARVN, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, RSU, Securities Exchange Act, Rule 10b5-1, Beneficial Ownership, Angela M. Cacace